CryoFuture
CryoFuture is a tech-enabled cryostorage and cryogenic transport company serving IVF clinics and fertility patients, operating seven U.S. storage facilities and a nationwide medical courier network with proprietary monitoring, RFID tracking, and a billing/consent platform.
- Company typePrivate
- Founded2022
- HeadquartersSan Mateo, United States
- Headcount1–10
- GTM typeB2B and B2C
- OfferingServices
What CryoFuture does
CryoFuture, Inc. is a San Mateo, California-based, tech-enabled cryostorage and cryogenic transportation company founded in 2022 that serves the fertility/IVF market. It operates a dual go-to-market model: enterprise field sales to IVF clinics and fertility laboratories, and a direct-to-consumer self-serve channel for individual patients storing eggs, sperm, and embryos. The company runs seven dedicated fertility storage facilities across the United States and operates its own nationwide medical courier network for specimen pickup and delivery. Named clinic/partner relationships include Winfility, Sunfish, and fertility-benefits provider Progyny.
The product portfolio combines physical infrastructure with software. Core services are Cryostorage (recurring storage of reproductive specimens) and Cryotransport (cryogenic shipping via the courier network). These are wrapped by proprietary monitoring systems — CryoFuture Signal and CryoFuture Vision — positioned to reduce human error in tank monitoring and handling, plus RFID tagging on all specimens for end-to-end traceability. CryoFuture One is the unified digital platform delivering automated billing, digital consents, inventory management for clinics, and patient onboarding/storage-plan access. Adjacent offerings include CryoAudit Inventory Integrity (inventory audits supporting CAP inspection readiness), a 24/7 Emergency Services Plan (tank replacement, bulk transfers, temporary storage), and protection programs (OmniSafe, Extra Protection Program, Transport Service Guarantee).
The revenue model blends recurring and usage-based streams: subscription/recurring storage fees and CryoFuture One platform fees, usage-based cryotransport, and professional-services revenue from audits and emergency interventions. Pricing is not publicly disclosed and is quote-based via sales or the platform. The company is private and founder-led (Sean Pae, Founder & CEO), employs 1–10 people, and in January 2026 received an undisclosed strategic investment from Chicago-based Liss Capital Partners to fund national expansion and continued technology investment.
CryoFuture firmographics
Firmographics- Name
- CryoFuture
- Legal name
- CryoFuture, Inc.
- Website
- https://cryofuture.co
- Company type
- Private
- Founded year
- 2022
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- CryoFuture is a tech-enabled cryostorage and cryogenic transport company serving IVF clinics and fertility patients, operating seven U.S. storage facilities and a nationwide medical courier network with proprietary monitoring, RFID tracking, and a billing/consent platform.
- Ownership category
- akta.pro rank
CryoFuture industry classification
Industry- Product category
- Fertility Specimen Cryostorage & Transportation
- NAICS
- Blood and Organ Banks (621991)
- SIC
- Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Cold Chain Storage & Cryopreservation Services (LN2/Ultra-low) (HLAGAGAK)
- akta.pro secondary industries
- Cryogenic Logistics (LN2 Dry Shippers, -150°C) (HLAGAMAB), Cold Chain, Cryopreservation & Biologics Storage/Handling Technologies (HLAAAJAN)
Keywords
Where CryoFuture is headquartered
LocationHeadquarters
- HQ city
- San Mateo
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
CryoFuture business model
Business model- GTM type
- B2B and B2C
- Offering type
- Services
- Cost components
- Infrastructure, Personnel, Supply Chain, Technology or R&D, Operations, Marketing or Sales
Revenue model
- Cryostorage Services: Recurring storage fees for fertility specimens at CryoFuture's facilities across the United States. Services include local storage, disaster-resistant facilities, and five-point security protocols.
- Cryotransport Services: Cryogenic transportation services for IVF clinics and patients, utilizing a nationwide medical courier network for safe specimen transport. Includes transport service guarantee and emergency support.
- CryoFuture One™ Platform Services: Integrated billing, inventory management, and consent management services for clinics, along with patient-facing storage plan management and billing access.
- Audit and Emergency Services: Expert inventory audit services (CryoAudit Inventory Integrity) for compliance and CAP inspection readiness, plus emergency services including tank replacements and bulk transfers.
Go-to-market motion2 records
Distribution channels3 records
Marketing channels6 records
CryoFuture product offering
Product offeringCore offering
CryoFuture provides tech-enabled cryostorage and cryogenic transportation services for fertility specimens (eggs, sperm, embryos) through seven dedicated facilities across the United States. Its offering combines physical cryogenic storage with a nationwide medical courier network, proprietary Signal™/Vision™ monitoring and RFID-based tracking systems, and CryoFuture One™, an integrated digital platform for automated billing, digital consents, and specimen management used by IVF clinics and patients. Complementary services include expert inventory audits (CryoAudit Inventory Integrity), 24/7 emergency tank replacement and bulk transfers, and structured protection programs (OmniSafe™) for additional specimen coverage.
Product overview
CryoFuture is a tech-enabled fertility specimen storage and transportation company operating a platform-plus-services model. The core offering consists of cryostorage and cryogenic transport services, supported by proprietary technology systems (CryoFuture Signal™ and CryoFuture Vision™) that minimize human error. CryoFuture One™ serves as the unified digital platform for both clinics and patients, providing automated billing, digital consents, and specimen management. Additional protection programs (CryoFuture OmniSafe™, Extra Protection Program, Transport Service Guarantee) and operational services (Emergency Services Plan, CryoAudit Inventory Integrity) round out the portfolio. The company operates seven dedicated fertility storage facilities across the United States.
Differentiator
Problem solved
Functional benefit
Brands
- CryoFuture One™: Automated billing, digital consents, and streamlined specimen management platform for clinics, providing patients secure onboarding, access to storage plans, and billing information.
- CryoFuture Signal™
- CryoFuture Vision™
- CryoFuture OmniSafe™
Products and services
- Cryostorage Recurring fertility specimen (egg, sperm, embryo) storage services across seven dedicated facilities in the United States, with state-of-the-art technology, five-point security protocols, disaster-resistant facilities, and 100% security monitoring. Sold primarily to IVF clinics via enterprise contracts and directly to individual patients via the CryoFuture One™ portal.
- Cryotransport Usage-based cryogenic transportation service for IVF clinics and patients via CryoFuture's nationwide medical courier network, ensuring safe, tracked transport of fertility specimens between clinics, storage facilities, and patient locations.
- CryoFuture One™ Platform Subscription-based unified digital platform providing automated billing, digital consents, and streamlined specimen management for IVF clinics, with patient-facing secure onboarding, storage plan access, and billing information via a self-serve portal.
- Emergency Services Plan 24/7 emergency support add-on providing tank replacements, bulk transfers, and temporary storage at the nearest CryoFuture facility to ensure specimens remain protected during equipment failures or other emergencies at customer sites.
- CryoAudit Inventory Integrity Professional inventory audit service that validates physical specimen inventory against digital records, supports CAP inspection readiness, and optimizes lab operations without disrupting patient care. Performed by CryoFuture's team of experienced embryologists and sold to IVF laboratories.
- CryoFuture OmniSafe™ Protection Program Standalone protection program for fertility specimens under CryoFuture's care, providing enhanced coverage safeguards across storage and transportation.
- Transport Service Guarantee Service guarantee program that ensures reliable, tracked specimen transportation through CryoFuture's nationwide medical courier network, complementing the core cryotransport offering.
Quantifiable outcome
- 0% specimen failure rate
- +2 more outcomes
Companies that use CryoFuture
Customer profileNamed customers4 records
Segments2 records
Ideal customer profiles2 records
CryoFuture technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
CryoFuture partnerships and signals
Strategic signalScale indicators4 records
Recent moves5 records
Expansion highlights5 records
CryoFuture competitors and assessment
Company assessmentBroad incumbents
- Inception Fertility: National network of fertility clinics with integrated cryostorage and lab services. Comparable as a vertically integrated incumbent that bundles storage with clinical care, competing for the same IVF clinic relationships.
- Cord Blood Registry (CBR): Operated by Generate Life Sciences, CBR is a large-scale cryogenic storage provider for newborn stem cells. Comparable in long-duration biological specimen storage infrastructure and chain-of-custody operations.
- Prelude Fertility: Large fertility services platform operating clinics and cryostorage infrastructure. Comparable as a broader reproductive-health incumbent with in-house storage capabilities that may reduce clinic appetite for outsourced solutions.
- Generate Life Sciences: Parent company of Fairfax Cryobank, CBR, and other reproductive tissue banks. Comparable as a broad incumbent with established cryogenic storage operations, donor networks, and clinic relationships that CryoFuture must compete against.
Direct peers
- Fairfax Cryobank: Established U.S. fertility cryobank providing sperm, egg, and embryo storage with national distribution. Comparable as a long-standing direct competitor in specimen cryopreservation.
- ReproTech: Specializes in long-term cryostorage and transportation of reproductive specimens (sperm, eggs, embryos) for fertility clinics and patients nationwide — a focused direct peer to CryoFuture's core service.
- Americord Registry: Cord blood and tissue cryobank offering long-term biological specimen storage and nationwide courier services — directly comparable to CryoFuture on storage-plus-transport model and patient-direct go-to-market.
- California Cryobank: One of the largest U.S. sperm, egg, and embryo cryobanks, offering long-term fertility specimen storage and transport — directly comparable to CryoFuture's core cryostorage offering for IVF clinics and patients.
- New England Cryogenic Center: Long-standing sperm and reproductive tissue bank offering cryostorage and donor specimen services, overlapping with CryoFuture's IVF clinic and patient cryopreservation focus.
Emerging players
- TMRW Life Sciences: Tech-enabled automated cryostorage platform for fertility specimens, targeting the same IVF clinic and patient market as CryoFuture but with a software-centric, in-clinic automation thesis.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
CryoFuture social profiles
Digital presenceCryoFuture financial estimates
Financial estimateRevenue estimate
Valuation estimate
CryoFuture leadership team
Management profileNumber of profiles
Profiles1 record
CryoFuture funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
CryoFuture M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about CryoFuture
What does CryoFuture do?
CryoFuture provides tech-enabled cryostorage and cryogenic transportation services for fertility specimens (eggs, sperm, embryos) through seven dedicated facilities across the United States. Its offering combines physical cryogenic storage with a nationwide medical courier network, proprietary Signal™/Vision™ monitoring and RFID-based tracking systems, and CryoFuture One™, an integrated digital platform for automated billing, digital consents, and specimen management used by IVF clinics and patients. Complementary services include expert inventory audits (CryoAudit Inventory Integrity), 24/7 emergency tank replacement and bulk transfers, and structured protection programs (OmniSafe™) for additional specimen coverage.
Is CryoFuture a public or private company?
CryoFuture is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was CryoFuture founded?
CryoFuture was founded in 2022. It employs 1 to 10 people.
Where is CryoFuture based?
CryoFuture is headquartered in San Mateo, United States, in the North America region.
How does CryoFuture make money?
Four revenue lines are on record. Cryostorage Services are the primary driver. The others are cryotransport Services, cryoFuture One™ Platform Services and audit and Emergency Services.
Who are CryoFuture's main competitors?
Broad incumbents on record are Inception Fertility, Cord Blood Registry (CBR), Prelude Fertility and Generate Life Sciences. Direct peers are Fairfax Cryobank, ReproTech, Americord Registry, California Cryobank and New England Cryogenic Center. TMRW Life Sciences is listed as an emerging player.
Does CryoFuture have an API?
No public API is recorded for CryoFuture.
What industry is CryoFuture in?
CryoFuture's product category is Fertility Specimen Cryostorage & Transportation. Its primary akta.pro industry code is HLAGAGAK, Cold Chain Storage & Cryopreservation Services (LN2/Ultra-low), with a secondary code of HLAGAMAB, Cryogenic Logistics (LN2 Dry Shippers, -150°C). Its NAICS code is 621991 and its SIC code is 8731.